Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Consolidated Financial Results for the Year Ended March 31, 2025 (Based on Japanese GAAP)
Consolidated Financial Results for the Year Ended March 31, 2025 (Based on Japanese GAAP)
Supplementary material for the financial results for the year ended March 31, 2025
Supplementary material for the financial results for the year ended March 31, 2025
Supplementary material for the financial results for the year ended March 31, 2025
Supplementary material for the financial results for the year ended March 31, 2025
Consolidated Financial Results for the Year Ended March 31, 2025 (Based on Japanese GAAP)
Notice of Revisions of Financial Forecasts
TOWA PHARMA, Last Fiscal Year Ordinary Profit Revised Upward to an Unexpected 7% Increase, Raises Record High Profit
Notice of Partial Revision of the Basic Policy for the Development of an Internal Control System
TOWA PHARMA, Oct-Dec (3Q) Ordinary Profit Increases by 65%, Current Fiscal Year Dividend Revised Upward by 10 yen
Notice of Revision of Dividend Forecasts for the Fiscal Year Ending March 31, 2025 (69th Fiscal Year)
Supplementary material for the financial results for the third quarter of the year ending March 31, 2025
Consolidated Financial Results for the Nine Months Ended December 31, 2024 (Based on Japanese GAAP)
TOWA PHARMACEUTICAL INTEGRATED REPORT 2024
Supplementary material for the financial results for the second quarter (interim period) of the year ending March 31, 2025
Consolidated Financial Results for the Six Months Ended September 30, 2024 (Based on Japanese GAAP)
TOWA PHARMACEUTICAL CO.,LTD., July-September (2Q) Ordinary Profit Decreases by 47%
TOWA PHARMACEUTICAL CO.,LTD., First Half Ordinary Profit Revised Upward to an Unexpected 1% Increase, Full Year also Increased
Notice of Revisions of Financial Forecasts